Free shipping on all orders over $ 500

Ganetespib

Cat. No. M1741

All AbMole products are for research use only, cannot be used for human consumption.

Ganetespib Structure
Synonym:

STA-9090

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 67  USD67 In stock
10mg USD 95  USD95 In stock
50mg USD 175  USD175 In stock
100mg USD 267  USD267 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ganetespib (STA-9090) is a potent synthetic small molecule inhibitor of Hsp90 with potential antineoplastic activity. Ganetespib (STA-9090) has shown strong activity in a broad range of preclinical solid and hematologic cancer models, including models highly resistant to treatment.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines NCI-H1975 and HCC827 cell lines
Preparation method Cell viability assays. Cells were grown in 96-well plates based on optimal growth rates determined empirically for each line. Twenty-four hours after plating, cells were treated with the indicated compounds or controls for 72 hours. AlamarBlue (Invitrogen) was added (10% v/v) to the cells, and the plates were incubated for 3 hours and, then, subjected to fluorescence detection. For the comparative viability/ apoptosis assay, NCI-H1975 cells were treated with escalating concentrations of ganetespib for the indicated time periods and subjected to viability analysis via CellTiter Fluor (Promega) and apoptosis via Caspase Glo 3/7 (Promega).
Concentrations 0~10 μM
Incubation time 6, 24, 48, and 72 hours
Animal Experiment
Animal models NCI-H1975 tumor xenograft-implanted SCID mice
Formulation formulated in 10/18 DRD (10% dimethyl sulfoxide, 18% Cremophor RH 40, 3.6% dextrose, 68.4% water)
Dosages 125 mg/kg for 6-72 hours
Administration oral gavage
Chemical Information
Molecular Weight 364.4
Formula C20H20N4O3
CAS Number 888216-25-9
Solubility (25°C) DMSO 37 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shimamura et al. Clin Cancer Res. Ganetespib (STA-9090), a Non-Geldanamycin HSP90 Inhibitor, has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer.

[2] Proia et al. Invest New Drugs. Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models.

[3] Ying et al. Mol Cancer Ther. Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.

[4] Proia et al. PLoS One. Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling.

Related HSP Products
NCT-58 

NCT-58 is a potent inhibitor of C-terminal HSP90.

Gedunin 

Gedunin is a limonoid with anti-cancer, anti-viral, anti-inflammatory and insecticidal activities.

VER-49009

VER-49009 is a Hsp90 inhibitor, with an IC50 of 25 nM and a Kd of 78 nM.

YUM70

YUM70 is a potent and selective inhibitor of glucose-regulated protein 78 (GRP78), with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity. YUM70 induces endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer.

Hsp70-derived octapeptide

Hsp70-derived octapeptide is a conserved octapeptide of the C-terminal end of Hsp70, which physically interacts with tetratricopeptide repeat (TPR) motifs.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ganetespib, STA-9090 supplier, HSP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.